Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of levodopa, carbidopa and entacapone for treating Parkinson's disease

Use of levodopa, carbidopa and entacapone for treating Parkinson's disease

US Patent 11771675 · Granted Oct 3, 2023

Estimated economic value: $8,813,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of levodopa, carbidopa and entacapone for treating Parkinson's disease2020
Use of levodopa, carbidopa and entacapone for treating Parkinson's disease2020
Use of levodopa, carbidopa and entacapone for treating Parkinson's disease2020
Use of levodopa, carbidopa and entacapone for treating Parkinson's disease2020
Agent for lowering endothelin levels2003
Treatment of obsessive compulsive disorder2002
Pharmacologically active catechol derivatives1995
Pharmacologically active compounds, methods for the preparation thereof and comp1994
Method of treating Parkinson's Disease using pentanedione derivatives1992